Larotrectinib: A Targeted Therapy for TRK Fusion Cancer What is Larotrectinib? Larotrectinib is an oral cancer treatment designed to specifically target NTRK gene fusions, a rare genetic abnormality that can…
What is Niraparib? Niraparib is an oral medication classified as a PARP inhibitor (Poly ADP-ribose polymerase inhibitor). It works by blocking the repair of damaged DNA in cancer cells, which…
Ponatinib: Uses, Benefits, Dosage, and Side Effects Ponatinib is a prescription medication used to treat certain types of leukemia. Marketed under the brand name Iclusig, Ponatinib is a tyrosine kinase…
Dacomitinib: Uses, Dosage, Side Effects & More Dacomitinib is a prescription medication used for the treatment of non-small cell lung cancer (NSCLC). As a targeted therapy, it works by inhibiting…
Reviews
There are no reviews yet.